Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Ravaud

Showing results (101-110 of 221) with videos related to

Pageof 23
Sort By:
European Journal of Cancer (Oxford, England : 1990)|October 16, 2021
Combining immune checkpoint inhibitors with chemotherapy in advanced solid tumours: A reviewMathieu Larroquette, Charlotte Domblides, Félix Lefort, et al.
BJU International|December 17, 2016
Sorafenib dose escalation in treatment-naïve patients with metastatic renal cell carcinoma: a non-randomised, open-label, Phase 2b studyMartin E Gore, Robert J Jones, Alain Ravaud, et al.
British Journal of Clinical Pharmacology|November 29, 2013
How to manage intravenous vinflunine in cancer patients with renal impairment: results of a pharmacokinetic and tolerability phase I studyNicolas Isambert, Jean Pierre Delord, Jean Marc Tourani, et al.
Bulletin Du Cancer|December 8, 2011
[Renal involvement in cancer and renal paraneoplastic syndromes]Juliette Thariat, Benoit Vendrely, Sophie Roca, et al.
Targeted Oncology|December 6, 2013
Survival outcomes of bevacizumab in first-line metastatic colorectal cancer in a real-life setting: results of the ETNA cohortAnnie Fourrier-Réglat, Denis Smith, Magali Rouyer, et al.
The Oncologist|March 2, 2010
Efficacy of sunitinib in advanced medullary thyroid carcinoma: intermediate results of phase II THYSUAlain Ravaud, Christelle de la Fouchardière, Julien Asselineau, et al.
Oncology|February 21, 2017
Relationship between Pulmonary Adverse Events and Everolimus Exposure in Japanese and Non-Japanese Patients: A Meta-Analysis of Oncology TrialsShinzaburo Noguchi, Nobuo Shinohara, Tetsuhide Ito, et al.
World Journal of Urology|December 18, 2015
Are we ready for day-case partial nephrectomy?Jean-Christophe Bernhard, Anne Payan, Henri Bensadoun, et al.
European Journal of Cancer (Oxford, England : 1990)|July 10, 2017
Immune checkpoint inhibitors and elderly people: A reviewAmaury Daste, Charlotte Domblides, Marine Gross-Goupil, et al.
Clinical Genitourinary Cancer|November 26, 2013
A phase II trial of sunitinib in patients with renal cell cancer and untreated brain metastasesChristine Chevreau, Alain Ravaud, Bernard Escudier, et al.
Pageof 23

Showing results (101-110 of 221) with videos related to

Sort By:
Pageof 23
European Journal of Cancer (Oxford, England : 1990)|October 16, 2021
Combining immune checkpoint inhibitors with chemotherapy in advanced solid tumours: A reviewMathieu Larroquette, Charlotte Domblides, Félix Lefort, et al.
BJU International|December 17, 2016
Sorafenib dose escalation in treatment-naïve patients with metastatic renal cell carcinoma: a non-randomised, open-label, Phase 2b studyMartin E Gore, Robert J Jones, Alain Ravaud, et al.
British Journal of Clinical Pharmacology|November 29, 2013
How to manage intravenous vinflunine in cancer patients with renal impairment: results of a pharmacokinetic and tolerability phase I studyNicolas Isambert, Jean Pierre Delord, Jean Marc Tourani, et al.
Bulletin Du Cancer|December 8, 2011
[Renal involvement in cancer and renal paraneoplastic syndromes]Juliette Thariat, Benoit Vendrely, Sophie Roca, et al.
Targeted Oncology|December 6, 2013
Survival outcomes of bevacizumab in first-line metastatic colorectal cancer in a real-life setting: results of the ETNA cohortAnnie Fourrier-Réglat, Denis Smith, Magali Rouyer, et al.
The Oncologist|March 2, 2010
Efficacy of sunitinib in advanced medullary thyroid carcinoma: intermediate results of phase II THYSUAlain Ravaud, Christelle de la Fouchardière, Julien Asselineau, et al.
Oncology|February 21, 2017
Relationship between Pulmonary Adverse Events and Everolimus Exposure in Japanese and Non-Japanese Patients: A Meta-Analysis of Oncology TrialsShinzaburo Noguchi, Nobuo Shinohara, Tetsuhide Ito, et al.
World Journal of Urology|December 18, 2015
Are we ready for day-case partial nephrectomy?Jean-Christophe Bernhard, Anne Payan, Henri Bensadoun, et al.
European Journal of Cancer (Oxford, England : 1990)|July 10, 2017
Immune checkpoint inhibitors and elderly people: A reviewAmaury Daste, Charlotte Domblides, Marine Gross-Goupil, et al.
Clinical Genitourinary Cancer|November 26, 2013
A phase II trial of sunitinib in patients with renal cell cancer and untreated brain metastasesChristine Chevreau, Alain Ravaud, Bernard Escudier, et al.
Pageof 23